RO
Therapeutic Areas
Prenetics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CircleDNA | Consumer Health, Wellness & Ancestry Insights | Approved/Commercial |
| COVID-19 PCR Testing | SARS-CoV-2 Diagnostic Testing | Approved/Commercial |
| ACT Genomics (OncoFusion) | Comprehensive Genomic Profiling for Solid Tumors | Approved/Commercial |
| ACT Genomics (OncoMixture) | Minimal Residual Disease Monitoring in Cancer | Approved/Commercial |
| Prenetics Wellness Panels | Corporate Health Risk Assessment | Approved/Commercial |
| ColoClear by Circle | Colorectal Cancer Screening | Approved/Commercial |
| Circle Pod | Metabolic Health Tracking (Continuous Glucose Monitoring) | Approved/Commercial |
| Circle Snapshot | At-home Blood Testing for Key Biomarkers | Approved/Commercial |
Leadership Team at Prenetics
DY
Danny Yeung
Co-Founder and Chief Executive Officer
SY
Siu Yung (S.Y.) Chau
Chief Financial Officer
AL
Avi Lasarow
Chief Executive Officer, EMEA
MY
Michael Yang
President, Asia
PS
Professor Sir John Bell
Board Member
CY
Ching Yee (C.Y.) Wong
Board Member
C(
Chun (Alex) Wu
Co-Founder and Board Member
DD
Dr. Dickson Leung
Head of Laboratory Operations (Hong Kong)
DW
Dr. Winnie Yeo
Director, Clinical Services (ACT Genomics)